Overview

A Phase I Trial of Simmitinib in Advanced Solid Tumors

Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is an open label, multi-center, phase I study of oral Simmitinib in subjects with advanced solid tumors including gastric cancer.
Phase:
Phase 1
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Collaborator:
Shanghai Runshi Pharmaceutical Technology Co., Ltd